Open access · US-GOV
via ClinicalTrials.gov Clinical trial
DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis
Authors not listed
Alnylam Pharmaceuticals · 2014
Abstract
The purpose of this study is to characterize the frequency of TTR mutations in subjects suspected of having cardiac amyloidosis
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Anonymous. (2014). DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis. <em>Alnylam Pharmaceuticals</em>. https://clinicaltrials.gov/study/NCT02252653
Vancouver
Anonymous. DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis. Alnylam Pharmaceuticals. 2014.
BibTeX
@misc{anon2014DISCOV,
title = {DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis},
author = {Anonymous},
journal = {Alnylam Pharmaceuticals},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mathew S. Maurer, MD 2019
Open access · US-GOV
Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations
University of Aarhus 2013
Open access · US-GOV
The Longevity of Trichuris Trichiura Colonization
National Institute of Allergy and Infectious Diseases (NIAID) 2006
Open access · US-GOV
Th1 Response to Influenza: Aging and Vaccine Efficacy
International Journal of Cardiology 2011
Citation only
Arterial stiffness and cardiovascular events: The Artscan study
CERESPIR 2010
Open access · US-GOV
Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects
Alcon Research 2015
Open access · US-GOV